iBio
IBIO
IBIO
70 hedge funds and large institutions have $17.5M invested in iBio in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 33 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
61% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 33
Holders
70
Holding in Top 10
–
Calls
$260K
Puts
$226K
Top Buyers
| 1 | +$186K | |
| 2 | +$43.2K | |
| 3 | +$36K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$23.2K |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
+$18.6K |
Top Sellers
| 1 | -$573K | |
| 2 | -$399K | |
| 3 | -$124K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$120K |
| 5 |
Man Group
London,
United Kingdom
|
-$114K |